Fluoride Ion

Fluoride Ion

SCHEMBL907407

COC[N+]1(C)CCCC1.[F-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.33
KMT2A Q03164 1/20 0.33
CHRNA7 P36544 1/20 0.33
TP53 P04637 1/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNA4 P43681 1/20 0.32
BBOX1 O75936 2/20 0.32
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride Ion SCHEMBL28908235 0.97 KDM4E (0.48) KDM4ELMNAKMT2ACHRNA7TP53
SCHEMBL1598394 0.97
Iodide SCHEMBL1769688 0.94 KDM4E (0.56) KDM4ELMNAKMT2ACHRNA7TP53
Hydrochloric Acid SCHEMBL2497190 0.94 KDM4E (0.50) KDM4ELMNAKMT2ATP53BBOX1
Bromide SCHEMBL1769727 0.94 KDM4E (0.50) KDM4ELMNAKMT2ATP53BBOX1
Hydrochloric Acid SCHEMBL907479 0.94 KDM4E (0.50) KDM4ELMNAKMT2ATP53BBOX1
SCHEMBL28908248 0.94 KDM4E (0.50) KDM4ELMNAKMT2ATP53BBOX1
Water SCHEMBL1769874 0.94 KDM4E (0.50) KDM4ELMNAKMT2ATP53BBOX1
SCHEMBL2099455 0.94 KDM4E (0.56) KDM4ELMNAKMT2ATP53CHRNB2
Bromide SCHEMBL9228369 0.92 KDM4E (0.54) KDM4ELMNAKMT2ATP53CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2172463-B1 Quaternary ammonium salt, electrolytic solution and electrochemical device OTSUKA CHEMICAL CO LTD (JP) 2015-06-17 EP disclosed
US-8747690-B2 Quaternary ammonium salt and composition, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2014-06-10 US disclosed
EP-1837333-B1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE OTSUKA CHEMICAL CO LTD (JP) 2013-04-10 EP disclosed
US-8366956-B2 Quaternary ammonium salt and composition, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2013-02-05 US disclosed
US-20130004860-A1 QUATERNARY AMMONIUM SALT AND COMPOSITION, AND ELECTROCHEMICAL DEVICE STELLA CHEMIFA CORPORATION (JP) 2013-01-03 US disclosed
US-20110123873-A1 Quaternary ammonium salt and composition, and electrochemical device STELLA CHEMIFA CORPORATION (JP) 2011-05-26 US disclosed
US-7875732-B2 Quaternary ammonium salt, electrolyte, electrolyte, solution and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2011-01-25 US disclosed
US-7834197-B2 Quaternary ammonium salt, electrolyte, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2010-11-16 US disclosed
EP-2172463-A1 Quaternary ammonium salt, electrolytic solution and electrochemical device Otsuka Chemical Co., Ltd. (JP) 2010-04-07 EP disclosed
US-20080050657-A1 N-methoxymethyl-N-methylpyrrolidinium trifluoromethanesulfonate; high solubility in organic solvents, high electroconductivity, voltage resistance; environmentally friendly; use in lithium battery; double layer capacitors STELLA CHEMIFA CORPORATION (JP) 2008-02-28 US disclosed
EP-1837333-A1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE Otsuka Chemical Co., Ltd. (JP) 2007-09-26 EP disclosed
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device OTSUKA CHEMICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1642894-A1 QUATERNARY AMMONIUM SALT, ELECTROLYTE, AND ELECTROCHEMICAL DEVICE OTSUKA CHEMICAL COMPANY, LIMITED (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080050657-A1 N-methoxymethyl-N-methylpyrrolidinium trifluoromethanesulfonate; high solubility in organic solvents, high electroconductivity, voltage resistance; environmentally friendly; use in lithium battery; double layer capacitors CACNA1F, KCNN2, KCNN3 KDM4E 942/4885LMNA 1998/4885KMT2A 1000/4885
US-20110123873-A1 Quaternary ammonium salt and composition, and electrochemical device DNMT3A, AFF4, AFF2 KDM4E 291/4885LMNA 4069/4885KMT2A 200/4885
US-20070042271-A1 Quaternary ammonium salt, electrolyte, and electrochemical device DNMT3A, NHERF1, SLC9A1 KDM4E 448/4885LMNA 2823/4885KMT2A 268/4885
US-20130004860-A1 QUATERNARY AMMONIUM SALT AND COMPOSITION, AND ELECTROCHEMICAL DEVICE DNMT3A, AFF4, AFF2 KDM4E 291/4885LMNA 4069/4885KMT2A 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.